IngentaConnect Search Results

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications

Authors: Abdel-Hamid, Ibrahim A; Andersson, Karl-Erik

Source: Pharmacogenomics, Volume 10, Number 10, October 2009 , pp. 1625-1644(20)

Erectile Dysfunction (ED) is a Shared Sexual Concern of Couples II: Association of Female Partner Characteristics with Male Partner ED Treatment Seeking and Phosphodiesterase Type 5 Inhibitor Utilization

Authors: Fisher, William A.; Eardley, Ian; McCabe, Marita; Sand, Michael

Source: The Journal of Sexual Medicine, Volume 6, Number 11, November 2009 , pp. 3111-3124(14)

Publisher: Blackwell Publishing

Phosphodiesterase Type 5 Inhibitors Facilitate Noncontact Erections in Male Rats: Site of Action in the Brain and Mechanism of Action

Authors: Sanna, Fabrizio; Succu, Salvatora; Boi, Antonio; Melis, Maria Rosaria; Argiolas, Antonio

Source: The Journal of Sexual Medicine, Volume 6, Number 10, October 2009 , pp. 2680-2689(10)

Publisher: Blackwell Publishing

Timing of Dose Relative to Sexual Intercourse Attempt in Previous Sildenafil Citrate Users Treated with Tadalafil: A Geographical Comparison from a Single Arm, Open-Label Study

Authors: Rubio-Aurioles, Eusebio; Glina, Sidney; Abdo, Carmita H.N.; Hernandez-Serrano, Ruben; Rampazzo, Claudia; Sotomayor, Mariano; West, Teena M.; Gallagher, Gabrielle L.; Lenero, Enrique

Source: The Journal of Sexual Medicine, Volume 6, Number 10, October 2009 , pp. 2836-2850(15)

Publisher: Blackwell Publishing

Should sildenafil be available over the counter?

Authors: Rubin, Naomi; Wylie, Kevan

Source: British Medical Bulletin, Volume 90, Number 1, 17 June 2009 , pp. 53-62(10)

Publisher: Oxford University Press

PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

Authors: Kouvelas, D.; Goulas, A.; Papazisis, G.; Sardeli, C.; Pourzitaki, C.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3464-3475(12)

Publisher: Bentham Science Publishers

Phosphodiesterase Type 5 Inhibitors: Unmet Needs

Authors: Hatzimouratidis, K.; Hatzichristou, D. G.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3476-3485(10)

Publisher: Bentham Science Publishers

Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment

Authors: Al-Shaiji, T. F.; Brock, G. B.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3486-3495(10)

Publisher: Bentham Science Publishers

PDE5 Inhibitors in the Treatment of LUTS

Author: Speakman, M. J.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3502-3505(4)

Publisher: Bentham Science Publishers

Is There a Role for PDE5 Inhibitors in the Management of Male Infertility Due to Defects in Testicular or Epididymal Function?

Authors: Dimitriadis, F.; Tsounapi, P.; Saito, M.; Watanabe, T.; Sylakos, A.; Tsabalas, S.; Miyagawa, I.; Sofikitis, N.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3506-3520(15)

Publisher: Bentham Science Publishers

PDE5 Inhibitors in Non-Urological Conditions

Authors: Vlachopoulos, C.; Terentes-Printzios, D.; Ioakeimidis, N.; Rokkas, K.; Stefanadis, C.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3521-3539(19)

Publisher: Bentham Science Publishers

Factors associated with phosphodiesterase type 5 inhibitor treatment satisfactions: results of patient interrogation

Authors: Cimen, Sertac; Demir, Omer; Aslan, Guven; Esen, Ahmet Adil

Source: The Aging Male, Volume 12, Numbers 2-3, June 2009 , pp. 58-61(4)

Publisher: Informa Healthcare

Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment

Authors: Foresta, Carlo; Di Mambro, Antonella; Caretta, Nicola; De Toni, Luca; Zuccarello, Daniela; Ferlin, Alberto

Source: Clinical Endocrinology, Volume 71, Number 3, September 2009 , pp. 412-416(5)

Publisher: Blackwell Publishing

2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)

Author: Shindel, Alan W.

Source: The Journal of Sexual Medicine, Volume 6, Number 9, September 2009 , pp. 2352-2364(13)

Publisher: Blackwell Publishing

Men's Sexual Health: Evaluating the Effectiveness of Print- and PDA-based CME

Authors: Broderick, Gregory A.; Abdolrasulnia, Maziar

Source: The Journal of Sexual Medicine, Volume 6, Number 9, September 2009 , pp. 2417-2424(8)

Publisher: Blackwell Publishing

Combination of Vacuum Erection Device and PDE5 Inhibitors as Salvage Therapy in PDE5 Inhibitor Nonresponders with Erectile Dysfunction

Authors: Canguven, Onder; Bailen, James; Fredriksson, William; Bock, David; Burnett, Arthur L.

Source: The Journal of Sexual Medicine, Volume 6, Number 9, September 2009 , pp. 2561-2567(7)

Publisher: Blackwell Publishing

Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

Authors: Roumeguère, Thierry; Zouaoui Boudjeltia, K.; Hauzeur, Claude; Schulman, Claude; Vanhaeverbeek, Michel; Wespes, Eric

Source: BJU International, Volume 104, Number 4, August 2009 , pp. 511-517(7)

Publisher: Blackwell Publishing

Phosphodiesterase inhibitors and the eye

Authors: Kerr, Nathan M; Danesh-Meyer, Helen V

Source: Clinical & Experimental Ophthalmology, Volume 37, Number 5, July 2009 , pp. 514-523(10)

Publisher: Blackwell Publishing

Toward a new `EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction

Authors: Sadovsky, R.; Brock, G. B.; Gutkin, S. W.; Sorsaburu, S.

Source: International Journal of Clinical Practice, Volume 63, Number 8, August 2009 , pp. 1214-1230(17)

Publisher: Blackwell Publishing

Five-year experience with tadalafil in the UK: an effective treatment for erectile dysfunction

Author: Dinsmore, W.

Source: International Journal of Clinical Practice, Volume 63, Number 8, August 2009 , pp. 1231-1236(6)

Publisher: Blackwell Publishing